Skip to content

The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children

The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01807299
Acronym
AOE
Enrollment
68
Registered
2013-03-08
Start date
2011-05-31
Completion date
2015-05-31
Last updated
2020-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder

Keywords

Physical Training, ADHD-Attention deficit hyperactivity disorder, Omega 3

Brief summary

The attention deficit hyperactivity disorder (ADHD) usually occurs in preschool and may cause disabilities through whole life.

Detailed description

The attention deficit hyperactivity disorder (ADHD) usually occurs in preschool and may cause disabilities through whole life. The treatment of this disease is expensive and difficult. Moreover, physical exercise and omegas consumption may improve the cognitive functions and behavior, so it could be an interesting strategy to improve this disorder. The aim of the present study is to verify the effects of multiple components physical training and the consumption of omega 3 on behavior, cognitive functions and the serum levels of BDNF and IGF-1 in ADHD children. Thus, 68 ADHD children, between seven and fourteen years old will be selected. The volunteers will be randomly divided into four groups: Physical Training Group (PTG), Omega Group (OG), Omega and Physical Training Group (OPTG) and Control Group (CG). The protocol of the experiment will last three months in which the OPTG will make physical training and receive fish oil capsules, and the PTG will make only the physical training and receive a placebo of fish oil. The others groups will be oriented not to make any type of physical training, but the OG will receive fish oil capsule, and the CG will receive a placebo of fish oil. Behavioral and cognitive functions evaluations and blood analysis will be made at the beginning and at the end of the protocol.

Interventions

DIETARY_SUPPLEMENTOmega 3

Capsules of omega 3, 1000mg / capsules. Administered 3 times a day.

OTHERPhysical Training

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
MALE
Age
7 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* Children with ADHD: male, between seven and fourteen years old, sedentary, studing in a regular school.

Exclusion criteria

* Taking psychoactive medications, taking omega supplement.

Design outcomes

Primary

MeasureTime frameDescription
Conners Scale3 monthsScores on the Conners scale. Scores above 60 indicate ADHD. Minimum 0 and a maximum of 126.

Countries

Brazil

Participant flow

Participants by arm

ArmCount
Omega-3 Only
Omega 3: Capsules of omega 3, 1000mg / capsules. Administered 3 times a day.
14
Sedentary (Control)
The sedentary group will be oriented not to make any type of physical training for three months. Omega 3: Capsules of omega 3, 1000mg / capsules. Administered 3 times a day.
14
Placebo + Phsycal Training
The omega 3 group will receive 2g per day of mineral oil during 90 days treatment Physical Training
12
Omega 3 + Phsycal Training
The omega 3 group will receive 2g per day of fish oil during 90 days treatment Physical Training
13
Total53

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyProtocol Violation3102

Baseline characteristics

CharacteristicOmega-3 OnlySedentary (Control)Placebo + Phsycal TrainingOmega 3 + Phsycal TrainingTotal
Age, Continuous10.27 years
STANDARD_DEVIATION 2.2
10.85 years
STANDARD_DEVIATION 2.03
10.36 years
STANDARD_DEVIATION 2.71
10.55 years
STANDARD_DEVIATION 2.94
10.5075 years
STANDARD_DEVIATION 2.47
Ethnicity (NIH/OMB)
Hispanic or Latino
14 Participants14 Participants12 Participants13 Participants53 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
00 Participants00 Participants00 Participants00 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
00 Participants00 Participants00 Participants00 Participants0 Participants
Region of Enrollment
Brazil
14 participants14 participants12 participants13 participants53 participants
Sex: Female, Male
Female
00 Participants00 Participants00 Participants00 Participants0 Participants
Sex: Female, Male
Male
14 Participants14 Participants12 Participants13 Participants53 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 140 / 140 / 120 / 13
serious
Total, serious adverse events
0 / 140 / 140 / 120 / 13

Outcome results

Primary

Conners Scale

Scores on the Conners scale. Scores above 60 indicate ADHD. Minimum 0 and a maximum of 126.

Time frame: 3 months

Population: Conners scale and the child stress scale (ESI)

ArmMeasureValue (MEAN)Dispersion
Omega-3 OnlyConners Scale36.64 units on a scaleStandard Deviation 12.75
Sedentary (Control)Conners Scale42.31 units on a scaleStandard Deviation 12.1
Placebo + Phsycal TrainingConners Scale40.08 units on a scaleStandard Deviation 14.47
Omega 3 + Phsycal TrainingConners Scale36.82 units on a scaleStandard Deviation 7.91
p-value: 0.05Chi-squared, Corrected

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026